Mild Cognitive Impairment and modifiable risk factors among Lebanese older adults in primary care

dc.contributor.authorAssaf, Georges
dc.contributor.authorEl Khoury, Jamil
dc.contributor.authorJawhar, Sarah
dc.contributor.authorRahme, Diana V.
dc.contributor.departmentFamily Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:42:29Z
dc.date.available2025-01-24T11:42:29Z
dc.date.issued2021
dc.description.abstractObjective: Mild Cognitive Impairment (MCI) is an intermediate state between normal cognition and dementia. Identification of MCI and associated risk factors is important for early intervention. This study investigated the prevalence of MCI among Lebanese older adults and associated risk factors in primary care. Methods: For this cross-sectional study, 337 adults aged 60 years and older met inclusion criteria and were recruited at a primary care clinic associated with a tertiary medical center in Beirut, Lebanon. The validated Arabic version of the Montreal Cognitive Assessment, the 5-item Geriatric Depression Scale, and the Lawton Instrumental Activities of Daily Living Scale were administered. Data about sociodemographic, behavioral, and clinical characteristics was obtained. Results: There was no difference in the mean age between those with normal cognition and those with MCI (mean age 70.38 ± 7.4 and 72.12 ± 7.6 years, respectively). The prevalence of MCI was 14.8% (50 out of 337), 42% were males and 58% were women. Participants having more than 12 years of education (OR = 0.297; CI = 0.112–0.788; P = 0.015) were less likely to have MCI. Participants with history of smoking (OR = 2.599; CI = 1.266–5.339; P = 0.012) or at risk of depression (OR = 2.847; CI = 1.392–5.819; P = 0.004) were more likely to have MCI. Conclusion: Identification of patients with history of smoking and at risk of depression may serve as an opportunity to offer intensive counseling and targeted treatment to delay the onset or progression of MCI to Alzheimer's disease. © 2021 Elsevier B.V.
dc.identifier.doihttps://doi.org/10.1016/j.ajp.2021.102828
dc.identifier.eid2-s2.0-85114844999
dc.identifier.pmid34507239
dc.identifier.urihttp://hdl.handle.net/10938/30024
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofAsian Journal of Psychiatry
dc.sourceScopus
dc.subjectAging
dc.subjectCognitive dysfunction
dc.subjectPrevalence
dc.subjectPrimary health care
dc.subjectRisk factors
dc.subjectActivities of daily living
dc.subjectAged
dc.subjectCross-sectional studies
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle aged
dc.subjectAntidepressant agent
dc.subjectHydroxymethylglutaryl coenzyme a reductase inhibitor
dc.subjectOpiate
dc.subjectSerotonin noradrenalin reuptake inhibitor
dc.subjectSerotonin uptake inhibitor
dc.subjectAdult
dc.subjectAnxiety
dc.subjectArticle
dc.subjectAsthma
dc.subjectBody mass
dc.subjectBrain surgery
dc.subjectCerebrovascular accident
dc.subjectChronic obstructive lung disease
dc.subjectCognition
dc.subjectCognitive defect
dc.subjectCongestive heart failure
dc.subjectControlled study
dc.subjectCoronary artery disease
dc.subjectCross-sectional study
dc.subjectDaily life activity
dc.subjectDementia
dc.subjectDemography
dc.subjectDepression
dc.subjectDiabetes mellitus
dc.subjectDyslipidemia
dc.subjectExercise
dc.subjectGeriatric depression scale
dc.subjectHuman
dc.subjectHypertension
dc.subjectHypothyroidism
dc.subjectKidney disease
dc.subjectLawton instrumental activities of daily living scale
dc.subjectLiver disease
dc.subjectMajor clinical study
dc.subjectMild cognitive impairment
dc.subjectMontreal cognitive assessment
dc.subjectPrimary medical care
dc.subjectQuestionnaire
dc.subjectRandomized controlled trial
dc.subjectRisk factor
dc.subjectSample size
dc.subjectSmoking
dc.subjectTransient ischemic attack
dc.subjectTraumatic brain injury
dc.subjectUnivariate analysis
dc.titleMild Cognitive Impairment and modifiable risk factors among Lebanese older adults in primary care
dc.typeArticle

Files